Vor Biopharma (VOR) Current Leases (2020 - 2026)
Vor Biopharma (VOR) reported Current Leases of $307000.0 for Q1 2026, down 92.8% year-over-year from $4.3 million in Q1 2025, and up 9.64% quarter-over-quarter from $280000.0 in Q4 2025.
Vor Biopharma (VOR) Current Leases (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Current Leases data on file, last reported at $307000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $307000.0, down 92.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $307000.0 (down 92.8% YoY), and the FY2025 annual result was $280000.0, down 93.36% from the prior year.
- Current Leases improved to $307000.0 in Q1 2026 per VOR's latest filing, from $280000.0 in the prior quarter.
- Over five years, Current Leases peaked at $7.3 million in Q1 2022 and troughed at $252000.0 in Q3 2025.
- A 5-year average of $3.5 million and a median of $3.8 million in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2025: Current Leases surged 530.39% in 2022, then slumped 93.95% in 2025.
- A 5-year view of Current Leases shows it stood at $3.3 million in 2022, then climbed by 17.05% to $3.8 million in 2023, then increased by 10.05% to $4.2 million in 2024, then tumbled by 93.36% to $280000.0 in 2025, then climbed by 9.64% to $307000.0 in 2026.
- Business Quant data shows VOR's Current Leases at $307000.0 in Q1 2026, $280000.0 in Q4 2025, and $252000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vor Biopharma | 627.54 Mn | 627.54 Mn | - | 307,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 307,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 252,000.00 |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | 4.22 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.69 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 3.76 Mn |
| Jun 30, 2022 | 4.43 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.16 Mn |
| Mar 31, 2021 | 1.16 Mn |